ERICHF program (early rehabilitation in cardiology heart failure) pilot study

• Main Author: Delgado, Bruno
• Publication Date: 2020
• Other Authors: Lopes, Ivo, Gomes, Bárbara, Novo, André
• Language: eng
• Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
• Download full: http://hdl.handle.net/10198/22861
• topic: Heart failure; Exercise; Rehabilitation; Functional capacity

Decompensated Heart Failure (HF) patients are often characterized by functional dyspnea, fatigue, edema, functional dependence and impairment of performance in activities of daily living. Aerobic exercise training (AET) is a well establish cardiac rehabilitation intervention which improves symptoms, promotes the functional capacity and even increase exercise tolerance. Although the benefits, exercise is not yet validated for inpatients during the phase of stabilization. Purpose: To evaluate the feasibility and safety of an AET program for patients admitted due to decompensated HF: ERICHF (Early Rehabilitation in Cardiology – Heart Failure) program Methods: Pilot randomized controlled singleblind trial Patients are randomized in training group (TG) or control group (CG). Data include cardiovascular history, HF history and two functional tools: London Chest of Daily Living Activities (LCADL) and Barthel Index (BI). TG patients performed the ERICHF program twice a day for 5 days per week. ERICHF program is a supervised AET program, with increasing levels of intensity, divided into 5 stages (respiratory training, cycloergometer training, gait training and climbing stairs, for progressive duration periods). Vital signs were evaluated before and immediately after the exercise, as well as the Borg Modified Perceived Exertion. CG patients performed physical activity in accordance with the guidelines available for inpatients, always supervised too. A sixminute walking test (6MWT) was performed as soon as patients are able to do it. At discharge, all patients perform another 6MWT, as so as evaluation of LCADL and BI. Results: 114 patients were randomized (64 in TG and 50 in CG) with an average of age of 72 (±9) years old, 70 are male, 82% are in NYHA class III. At admission, both groups have the same level of functional dependence according to LCADL (31 vs 32) and Barthel (73 vs 73) scores. TG patients performed 932 sessions of exercise, with an average of 17 sessions each, for 15 (±9) days of hospitalization. There is a difference of 83 meters between the two 6MWT performed by TG patients, which demonstrates clinical significance. At discharge, TG patients presented lower LCADL score (12 vs 16, p=0,006), higher BI (98 vs 92, p=0,038) score and a 64 meters difference on the 6MWT (p=0,0032) which represents a better functional capacity. There were absence of adverse events like falls, precordial pain, malignant arrhythmias and worsening of clinical state Conclusions: ERICHF program demonstrated, in this sample of patients, to be safe and to promote functional capacity. We can also infer that probably AET is safe and viable, for this kind of patients, related to the absence of adverse events. No other study of our knowledge has demonstrated this findings.